AzTrials
AzTrials

Horizontal Strabismus With High AC/A RatioPhase 2/3NCT03555045

The Effect of Slanted Recession of Horizontal Muscle on Horizontal Strabismus With Abnormal Accommodative Convergence /Accommodation Ratio (AC/A)

A Phase 2/3 study testing conducting the slanted recession technique on the superior and inferior poles and conducting the augmented recession technique on the muscle in people with Horizontal Strabismus With High AC/A Ratio, run by Shahid Beheshti University of Medical Sciences at 1 site in Iran.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Different methods was tried to treat high AC/A strabismus cases;such as prescription of bifocal glasses in esotropia,recession of horizontal muscles with posterior fixation sutures,more recession than needed for far deviation(augmented recession),recession and pulley fixation and slant recession. Read more about this study

Who is it for?
Ages 6 to 80 yearsHealthy volunteers can take part
What is being tested?
conducting the slanted recession technique on the superior and inferior poles and conducting the augmented recession technique on the muscle
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteIran
Study dates
1 Feb 2017to May 2019
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • all patients with horizontal strabismus that the different between far deviation and near deviation is more than 10 pd

Who cannot join

  • all patients who had history of surgery on horizontal muscles and patients with pseudo high AC/A ratio.

Trial locations and contacts

1 site in 1 country.

zhaleh rajavi, MD contact

9822591616

labbafi@hotmail.com

Iran1 site, 1 recruiting
  • Ophthalmic Research Center

    Tehran

    zhaleh Rajavi, MD, 9822591616, labbafi@hotmail.com

    Recruiting

Other trials in Iran

About this study

Different methods was tried to treat high AC/A strabismus cases;such as prescription of bifocal glasses in esotropia,recession of horizontal muscles with posterior fixation sutures,more recession than needed for far deviation(augmented recession),recession and pulley fixation and slant recession.

Different results was reported for any type of above methods. In recent studies,slanted recession was applied for high AC/A in esotropic cases and success rate of 67% was reported.but there was no unanimity for procedure of choice.

Since slant recession method is simpler and has low side effect than the other methods,therefore in this study the investigators want to peruse the outcome of this method on high AC/A horizontal strabismus.

Being tested
conducting the slanted recession technique on the superior and inferior poles, conducting the augmented recession technique on the muscle

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • conducting the slanted recession technique on the superior and inferior polesProcedure or surgery

    conducting the slanted recession technique on the superior and inferior poles of the muscle based on far and near deviations.

  • conducting the augmented recession technique on the muscleProcedure or surgery

    conducting the augmented recession technique on the muscle for 1 to 1.50 mm more compared with the standard method.

Study groups in NCT03555045
Study groupRoleWhat they receive
conducting the slanted recession techniqueActive comparatorconducting the slanted recession technique on the superior and inferior poles of the muscle based on far and near deviations.
Receives: Procedure: conducting the slanted recession technique on the superior and inferior poles
conducting the augmented recession technique on the muscleActive comparatorconducting the augmented recession technique on the muscle for 1 to 1.50 mm more compared with the standard method.
Receives: Procedure: conducting the augmented recession technique on the muscle

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. far-near deviation difference

    difference between the far and near deviations

    Measured: 90 days after surgery

Secondary outcomes (1)
  1. success rate of surgery

    in cases with difference of far and near deviation less than 10 prism diopters

    Measured: 90 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2018
  2. Study start1 Feb 2017
  3. Primary completion1 Jul 2017
  4. Study completionMay 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03555045
Sponsor's protocol ID
96302
Status last verified
Jan 2018
First submitted
11 Apr 2018
Last updated
13 Jun 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing conducting the slanted recession technique on the superior and inferior poles and conducting the augmented recession technique on the muscle in people with Horizontal Strabismus With High AC/A Ratio, run by Shahid Beheshti University of Medical Sciences at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact zhaleh rajavi, MD (9822591616, labbafi@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

far-near deviation difference (time frame: 90 days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in